Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Terminated 2Completed 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 1Hematological Infection 1Gram-Negative Bacterial Infections 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Colistin × Clear all
NCT03397914 2020-09-16

Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections

National Cancer Institute, Egypt

Phase 4 Completed
70 enrolled

Neoplasms, Gram-Negative Bacterial Infections

NCT02966457 2017-12-28

DEHAM

Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology

Phase 4 Completed
62 enrolled

Hematological Infection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡